Literature DB >> 31550642

Epidemiology of bronchiectasis in the UK: Findings from the British lung foundation's 'Respiratory health of the nation' project.

Noel Snell1, Jack Gibson2, Ian Jarrold3, Jennifer K Quint4.   

Abstract

Key findings of this national survey of non-cystic fibrosis bronchiectasis epidemiology were that its prevalence, incidence and mortality have all increased over recent years; we estimate that around 212,000 people are currently living with bronchiectasis in the UK, very much higher than commonly quoted figures. Bronchiectasis is more common in females than males; 60% of diagnoses are made in the over-70 age group. Regional differences in prevalence, incidence, mortality, and hospital admission were identified. An intriguing finding was that bronchiectasis is more commonly diagnosed in the least deprived sections of the population, in contrast to other respiratory disorders.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  Bronchiectasis; Epidemiology

Year:  2019        PMID: 31550642     DOI: 10.1016/j.rmed.2019.09.012

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  9 in total

Review 1.  Respiratory Mycoses in COPD and Bronchiectasis.

Authors:  Pei Yee Tiew; Micheál Mac Aogáin; Soo Kai Ter; Stefano Aliberti; James D Chalmers; Sanjay H Chotirmall
Journal:  Mycopathologia       Date:  2021-03-11       Impact factor: 2.574

Review 2.  Diagnosis and management of non-cystic fibrosis bronchiectasis.

Authors:  Laura Macfarlane; Kartik Kumar; Thomas Scoones; Andrew Jones; Michael R Loebinger; Robert Lord
Journal:  Clin Med (Lond)       Date:  2021-11       Impact factor: 2.659

3.  Strong and consistent associations of precedent chronic rhinosinusitis with risk of non-cystic fibrosis bronchiectasis.

Authors:  Brian S Schwartz; Saba A Al-Sayouri; Jonathan S Pollak; Annemarie G Hirsch; Robert Kern; Bruce Tan; Atsushi Kato; Robert P Schleimer; Anju T Peters
Journal:  J Allergy Clin Immunol       Date:  2022-03-18       Impact factor: 14.290

4.  'It's not one size fits all': a qualitative study of patients' and healthcare professionals' views of self-management for bronchiectasis.

Authors:  Carol Ann Kelly; Anthony Tsang; Dave Lynes; Sally Spencer
Journal:  BMJ Open Respir Res       Date:  2021-03

5.  The self-management abilities test (SMAT): a tool to identify the self-management abilities of adults with bronchiectasis.

Authors:  Katelyn R Smalley; Lisa Aufegger; Kelsey Flott; Erik K Mayer; Ara Darzi
Journal:  NPJ Prim Care Respir Med       Date:  2022-01-14       Impact factor: 2.871

6.  Utility of a personalised Bronchiectasis Action Management Plan (BAMP) for children with bronchiectasis: protocol for a multicentre, double-blind parallel, superiority randomised controlled trial.

Authors:  Julie M Marchant; Anne B Chang; Kobi L Schutz; Lesley Versteegh; Anne Cook; Jack Roberts; Peter S Morris; Stephanie T Yerkovich; Gabrielle B McCallum
Journal:  BMJ Open       Date:  2021-12-22       Impact factor: 2.692

7.  Epidemiology and economic burden of bronchiectasis requiring hospitalisation in Singapore.

Authors:  Hwee Pin Phua; Wei-Yen Lim; Ganga Ganesan; Joanne Yoong; Kelvin Bryan Tan; John Arputhan Abisheganaden; Albert Yick Hou Lim
Journal:  ERJ Open Res       Date:  2021-10-25

8.  Female Reproductive Factors and the Risk of Bronchiectasis: A Nationwide Population-Based Longitudinal Study.

Authors:  Bumhee Yang; Dong-Hwa Lee; Kyungdo Han; Hayoung Choi; Hyung Koo Kang; Dong Wook Shin; Hyun Lee
Journal:  Biomedicines       Date:  2022-01-28

9.  Airway acidification impaired host defense against Pseudomonas aeruginosa infection by promoting type 1 interferon β response.

Authors:  Yang Liu; Ying-Zhou Xie; Yi-Han Shi; Ling Yang; Xiao-Yang Chen; Ling-Wei Wang; Jie-Ming Qu; Dong Weng; Xiao-Jian Wang; Hai-Peng Liu; Bao-Xue Ge; Jin-Fu Xu
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 19.568

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.